Qin Liu

engineering research center of modern chinese medicine

H指数:24

被引数:1,968

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tetrandrine-loaded manganese-doped ceria nanozyme for nebulized inhalation therapy of the ROS-driven inflammatory-fibrotic continuum

四氢巴马汀负载的锰掺杂二氧化铈纳米酶用于ROS驱动的炎症-纤维化连续体的雾化吸入治疗

Journal of Nanobiotechnology

IF12.6

2026-09-220

OAAI

A bio-orthogonally engineered probiotic-T cell chimera amplifies adoptive cell therapy through spatial DC-T cell immune licensing

一种经生物正交工程改造的益生菌-T细胞嵌合体通过空间DC-T细胞免疫授权增强过继细胞疗法

Science Bulletin

IF21.1

2026-09-040

OAAI

Intranodal injection of PD1 antibody enhances memory T cell responses to improve the efficacy of neoantigen vaccines

淋巴结内注射PD1抗体增强记忆T细胞反应以改善新抗原疫苗的疗效

Biochemical Pharmacology

IF5.6

2026-08-050

PRE

Toosendanin enhances endothelial repair and prevents inflammation via E2F1 mediated LINC01089

Naunyn-Schmiedeberg's Archives of Pharmacology

IF3.1

2026-01-140

PRE

Real-World Efficacy and Safety of Disitamab Vedotin (RC48-ADC) in the Treatment of HER2-Overexpressing Advanced Gastric/Gastroesophageal Junction Cancer

Current Oncology

IF3.4

2025-12-190

OAAI

A real-world retrospective analysis to evaluate the efficacy and safety of surufatinib in the treatment of advanced neuroendocrine neoplasms in China

ENDOCRINE CONNECTIONS

IF2.8

2025-11-010

PRE

Nanomaterial signatures program biomolecular condensates via triphasic separation for chemoplasticity remodeling

纳米材料特征通过三相分离程序化生物分子凝聚体，以重塑化学可塑性。

Nature Communications

IF15.7

2025-10-290

OAAI

Engineered Lactococcus lactis biovaccine containing NY-ESO-1 long peptides as potent immunotherapeutics

工程化乳酸乳球菌生物疫苗，包含NY-ESO-1长肽作为强效免疫治疗剂

Materials Today Bio

IF10.2

2025-10-200

OAAI

Gut microbe-derived aromatic trace amines mediate individual variability in response to herbal medicine CDD-2101 for functional constipation

肠道微生物衍生的芳香族微量胺介导对功能性便秘草本药物CDD-2101反应的个体差异性

Pharmacological Research

IF10.5

2025-05-300

Bladder cancer biomarker analysis and drugtarget prediction based on pyroptosis-related genes

基于焦亡相关基因的膀胱癌生物标志物分析及药物靶点预测

DISCOVER ONCOLOGY

IF2.9

2025-05-250

Defining gastric cancer ecology: the crucial roles of TREM2+ macrophages and fibroblasts in tumor microenvironments

定义胃癌生态学：TREM2+巨噬细胞和成纤维细胞在肿瘤微环境中的关键作用

COMMUNICATIONS BIOLOGY

IF5.1

2025-03-280

Analysis of tumor-infiltrating exhausted T cells highlights IL-6 and PD1 blockade as a combined immunotherapy strategy for non-small cell lung cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-02-110

OAAI

A panel of cancer testis antigens in squamous cell carcinoma of the lung, head and neck, and esophagus: implication for biomarkers and therapeutic targets

肺、头颈和食管鳞状细胞癌中一组癌睾丸抗原：对生物标志物和治疗靶点的意义

DISCOVER ONCOLOGY

IF2.9

2025-01-260

A multifunctional mesoporous silica drug delivery nanosystem that ameliorates tumor hypoxia and increases radiotherapy efficacy

NPG ASIA MATERIALS

IF8.3

2024-08-160

An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: 'R-ISV-FOLactis' trial

FUTURE ONCOLOGY

IF2.6

2024-07-210

PRE

Low-dose doxorubicin loaded extracellular vesicles combined Fas/FasL pathway-mediated chemo-sensitization and immunotherapy against tumor

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2024-07-013

PRE

Injectable thermo-sensitive hydrogel enhances anti-tumor potency of engineered Lactococcus lactis by activating dendritic cells and effective memory T cells

BIOACTIVE MATERIALS

IF20.3

2024-07-014

OAAI

In situ chemoimmunotherapy hydrogel elicits immunogenic cell death and evokes efficient antitumor immune response

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2024-04-094

OAAI

Intra-bone marrow injection with engineered Lactococcus lactis for the treatment of metastatic tumors: Primary report

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2024-04-011

OAAI

Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors

FUTURE ONCOLOGY

IF2.6

2024-03-060

Qin Liu

个人简介

教育背景

工作经历

荣誉奖项

研究方向